KeraCure hopes to outperform rivals with cell-based wound dressing
This article was originally published in Clinica
Executive Summary
Advanced wound care firm KeraCure has begun a pilot study of its human skin cell-based dressing, KeraPac, which it believes could penetrate the market more successfully than rival products.